The Wharton Moneyball Post Game Podcast


Wharton Moneyball: MLB Hall of Fame, NFL Field Analytics, Coaching, & E-Sports

Ep. 130

Show from 12/19/18

In this episode, the final show of 2018, hosts Eric Bradlow and Adi Wyner start off the show talking about who deserves to be in the MLB Hall of Fame and who is a fringe player. Could Babe Ruth play in today's game? Then, what's new in NFL analytics? An expert on the subject joins our hosts to talk about how uses large datasets to learn about human behavior. Plus a look at coahcing development, E-Sports, and our Moneyball Matchups. Tune in!


Ben Baldwin - An economist by trade as he uses large datasets to try to learn about human behavior. Ben joined The Athletic after previously covering the Seahawks for Field Gulls.

Follow him on Twitter @benbbaldwin

Rob Ash - Championship Analytics Director of Coaching Development. I company works to integrate world-class analytics with a coach’s insight to take the guesswork out of in-game decision making and is working with teams in the NFL, Big Ten, SEC, Pac-12, ACC and more. Coach Ash is responsible for creating CAI’s football strategy curriculum and for working directly with CAI client head coaches to improve our clients’ in-game football strategy performance. 

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.